EN DE
STOCK COMPARISON

Medipower -M vs CBRE Group Inc Class A: Fair Value & Quality

Both stocks run through our valuation models. Here is how Medipower -M (MDPR) and CBRE Group Inc Class A (CBRE) compare, as of Aug 28, 2026.

As of Aug 28, 2026, Fair Value Calculator sees Medipower -M as the less overvalued of the two: Medipower -M trades at ILS 5.14 versus a fair value of ILS 4.48 (-13%), while CBRE Group Inc Class A trades at $147 versus $69.47 (-53%).
Medipower -M
MDPR.TA · ILA · Real Estate
-13%
upside to fair value
overvalued
PriceILS 5.14
Fair ValueILS 4.48
Quality59/100
CBRE Group Inc Class A
CBRE · USD · Real Estate
-53%
upside to fair value
overvalued
Price$147
Fair Value$69.47
Quality54/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Medipower -MCBRE Group Inc Class A
Valuation
50.8×P/E (TTM)31.9×
6.12×P/S (TTM)0.97×
1.80×P/B4.60×
8.5×EV/EBITDA20.0×
PEG0.74×
0.5%Dividend yield0.0%
Profitability
22%Net margin3%
56%Operating margin3%
7%Return on equity16%
3%Return on assets3%
Growth
20%Revenue growth (YoY)19%
6.1%Avg. growth/yr (3Y)9.6%
13.3%Avg. growth/yr (5Y)11.2%
Balance & size
0.85×Debt / equity0.57×
$89MMarket cap$41B
mixedGrowth qualityhealthy

Medipower -M leads: 7 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Medipower -Mof which business quality 56 · market factors 34 CBRE Group Inc Class Aof which business quality 53 · market factors 44
ProfitabilityMargins and returns on capital today
37
49
Quality GrowthAre margins and returns improving?
32
33
CashflowEarnings quality: real cash, not paper profit
89
44
Fin. StrengthBalance sheet, leverage, solvency risk
37
38
InvestmentDisciplined investing over empire-building
70
69
Low VolatilityCalm price path (market factor)
81
54
MomentumPrice trend over the last 3–12 months (market factor)
21
43
52W MomentumDistance to the 52-week high (market factor)
3
36
Net IssuanceBuybacks instead of dilution
81
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Medipower -M

DCF ModelsILS 9.08
Dividend DiscountILS 0.39
MultiplesILS 5.15
Asset-BasedILS 1.92
Growth DCFILS 7.54
Economic ProfitILS 2.46

6 of 16 models see the stock below the current price.

CBRE Group Inc Class A

DCF Models$94.30
Dividend Discount$0.81
Multiples$67.17
Asset-Based$20.31
Growth DCF$77.97
Economic Profit$36.48

16 of 16 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Medipower -M
Bear ILS 3.36Fair Value ILS 4.48Bull ILS 5.60
ILS 5.14 = current price (white tick)
CBRE Group Inc Class A
Bear $40.20Fair Value $69.47Bull $93.77
$147 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Medipower -M · Real Estate

Quality score59 · above median
Fair value upside-13% · below median

CBRE Group Inc Class A · Real Estate

Quality score54 · above median
Fair value upside-53% · bottom 25%

Bottom line

As of Aug 28, 2026, Fair Value Calculator sees Medipower -M as the less overvalued of the two: Medipower -M trades at ILS 5.14 versus a fair value of ILS 4.48 (-13%), while CBRE Group Inc Class A trades at $147 versus $69.47 (-53%).

Medipower -M has the higher quality score (59/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.